Drug Company Leaders Condemn Ruling Invalidating F.D.A. Approval of Abortion Pill

Health
By BY CHRISTINA JEWETT from NYT Health https://ift.tt/Pj0gSu8
via IFTTT Drugs (Pharmaceuticals), Decisions and Verdicts, Abortion, Mifeprex (RU-486), Abortion Drugs, Biotechnology and Bioengineering More than 250 executives said that the decision ignored both scientific and legal precedent and, if it stands, would create uncertainty for the entire pharmaceutical and biotech industries.

Comments

Post a Comment

Popular posts from this blog

F.D.A. Poised to Restrict Access to Covid Vaccines

Image
Health By Christina Jewett and Apoorva Mandavilli from NYT Health https://ift.tt/VHvAQN8 via IFTTT Vaccination and Immunization, Coronavirus (2019-nCoV), Regulation and Deregulation of Industry, Rumors and Misinformation, Clinical Trials, Medicine and Health Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many others may not be able to get the shots.
Read more

U.S. Will No Longer Recommend Covid Shots for Children and Pregnant Women

Image
Health By Apoorva Mandavilli and Christina Jewett from NYT Health https://ift.tt/lefLSPp via IFTTT Vaccination and Immunization, Children and Childhood, United States Politics and Government, Regulation and Deregulation of Industry, Babies and Infants, Pregnancy and Childbirth, Coronavirus (2019-nCoV) Health Secretary Robert F. Kennedy Jr. announced that the vaccine would not be included as part of the immunization schedule for healthy children.
Read more